Clinical trial · Observational
Collecting and Storing Tissue Samples From Women With or Without Breast Cancer
Breast Tissue/Body Fluids Repository
NCT00899301CI-TRIAL-00123676recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
RATIONALE: Collecting and storing samples of tissue, blood, and urine from patients with or without breast cancer to study in the laboratory may help the study of cancer. PURPOSE: This research study is collecting and storing tissue samples from women with or without breast cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| biologic sample preservation procedure | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Patients with Breast Cancer
- interventionNames
- Other: biologic sample preservation procedure
- label
- Patients without breast cancer
- interventionNames
- Other: biologic sample preservation procedure
Primary outcomes (1)
- measure
- Creation of a tissue repository that contains DNA, RNA, or protein from tumor tissue or normal tissue, peripheral blood lymphocytes, and plasma that are linked to frozen and/or paraffin-embedded pathology specimens
- timeFrame
- 5 years
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
* Breast lesion which is suspected to be cancer or a known diagnosis of breast cancer (any stage, at any point in the disease trajectory) who agrees to donate tissue/body fluids. * Individuals of all races and ethnic groups are eligible for this trial. There is no restriction regarding age, race, or ethnicity. The trial is open to the accrual of men and women. * Must sign informed consent for study of tumor specimens as part of a research project. * Must give permission for their tumor specimens to be obtained from outside institutions for molecular analyses. * Must be willing to be followed for recurrence, relapse and death from disease. ELIGIBILITY CRITERIA FOR OPTIONAL PHYSICAL FUNCTION AND COGNITIVE ASSESSMENTS * Must be 60 years of age or older * Have completed initial round of cancer treatment * Have completed the optional online survey and opted-in for the physical function and cognitive assessments
References
Publications (0)
Data not yet available
No reference posted for this study.